рмПрм╣рм┐ рмЗрммрнБрмХрнН рммрм┐рм╖рнЯрм░рнЗ
This book contains a selection of the papers presented at the meeting "Between Clone and Clinic" which was organised in March 1990 in Amsterdam by the dutch Organisation for Applied Research, TNO, and the University of Utrecht. The scope of this meeting was the development of biotechnological pharmaceuticals mainly made by recombinant DNA technology or monoclonal antibody techniques. All aspects concerning the development of the products after host cells producing them are obtained where discussed. The meeting was attended by twohundred specialists from all over the globe, including phar macologists, toxicologists, registration experts, Quality Assurence managers, production en gineers and physicians. Biotechnological pharmaceuticals are in general large and complex protein molecules. Bringing these products to the market poses other problems than encountered with the classical chemical drugs. The source of biotechnological pharmaceuticals are living cells. The function of cells are depend ent on many factors and the stability of production may be a problem. Good Laboratory and Manufactory Practices with Quality Control (GLP and GMP) are of paramount importance and are discussed in a number of papers. The products of the new biotechnology are often highly specific and only active in the human species. Also the side effects can only be studied in the clinical setting. Even when the product is active in animals there is the problem of antigenicity. During treatment the animals will produce antibodies which neutralise the activity. So safety testing may prove difficult.
This book contains a selection of the papers presented at the meeting "Between Clone and Clinic" which was organised in March 1990 in Amsterdam by the dutch Organisation for Applied Research, TNO, and the University of Utrecht. The scope of this meeting was the development of biotechnological pha...
рмЕрмзрм┐рмХ рмбрм┐рм╕рнНрмХрмнрм░ рмХрм░рмирнНрмдрнБ
рмПрм╣рм┐ рмЗрммрнБрмХрнНтАНрмХрнБ рморнВрм▓рнНрнЯрм╛рмЩрнНрмХрми рмХрм░рмирнНрмдрнБ
рмЖрмкрмг рмХрмг рмнрм╛рммрнБрмЫрмирнНрмдрм┐ рмдрм╛рм╣рм╛ рмЖрмормХрнБ рмЬрмгрм╛рмирнНрмдрнБред
рмкрнЭрм┐рммрм╛ рмкрм╛рмЗрмБ рмдрмернНрнЯ
рм╕рнНрморм╛рм░рнНрмЯрмлрнЛрми рмУ рмЯрм╛рммрм▓рнЗрмЯ
Google Play Books рмЖрмкрнНрмХрнБ, Android рмУ iPad/iPhone рмкрм╛рмЗрмБ рмЗрмирм╖рнНрмЯрм▓рнН рмХрм░рмирнНрмдрнБред рмПрм╣рм╛ рм╕рнНрм╡рмЪрм╛рм│рм┐рмд рмнрм╛рммрнЗ рмЖрмкрмгрмЩрнНрмХ рмЖрмХрм╛рмЙрмгрнНрмЯрм░рнЗ рм╕рм┐рмЩрнНрмХ рм╣рнЛтАНрмЗрмпрм┐рмм рмПрммрмВ рмЖрмкрмг рмпрнЗрмЙрмБрмарм┐ рмерм╛рмЖрмирнНрмдрнБ рмирм╛ рмХрм╛рм╣рм┐рмБрмХрм┐ рмЖрмирм▓рм╛рмЗрмирнН рмХрм┐рморнНрммрм╛ рмЕрмлрм▓рм╛рмЗрмирнНтАНрм░рнЗ рмкрнЭрм┐рммрм╛ рмкрм╛рмЗрмБ рмЕрмирнБрмормдрм┐ рмжрнЗрммред
рм▓рм╛рмкрмЯрмк рмУ рмХрморнНрмкрнНрнЯрнБрмЯрм░
рмирм┐рмЬрм░ рмХрморнНрмкрнНрнЯрнБрмЯрм░рнНтАНрм░рнЗ рмерм┐рммрм╛ рн▒рнЗрммрнН рммрнНрм░рм╛рмЙрмЬрм░рнНтАНрмХрнБ рммрнНрнЯрммрм╣рм╛рм░ рмХрм░рм┐ Google Playрм░рнБ рмХрм┐рмгрм┐рмерм┐рммрм╛ рмЕрмбрм┐рмУрммрнБрмХрнНтАНрмХрнБ рмЖрмкрмг рм╢рнБрмгрм┐рмкрм╛рм░рм┐рммрнЗред
рмЗ-рм░рм┐рмбрм░рнН рмУ рмЕрмирнНрнЯ рмбрм┐рмнрм╛рмЗрм╕рнНтАНрмЧрнБрнЬрм┐рмХ
Kobo eReaders рмкрм░рм┐ e-ink рмбрм┐рмнрм╛рмЗрм╕рмЧрнБрмбрм╝рм┐рмХрм░рнЗ рмкрмврм╝рм┐рммрм╛ рмкрм╛рмЗрмБ, рмЖрмкрмгрмЩрнНрмХрнБ рмПрмХ рмлрм╛рмЗрм▓ рмбрм╛рмЙрмирм▓рнЛрмб рмХрм░рм┐ рмПрм╣рм╛рмХрнБ рмЖрмкрмгрмЩрнНрмХ рмбрм┐рмнрм╛рмЗрм╕рмХрнБ рмЯрнНрм░рм╛рмирнНрм╕рмлрм░ рмХрм░рм┐рммрм╛рмХрнБ рм╣рнЗрммред рм╕рморм░рнНрмерм┐рмд eReadersрмХрнБ рмлрм╛рмЗрм▓рмЧрнБрмбрм╝рм┐рмХ рмЯрнНрм░рм╛рмирнНрм╕рмлрм░ рмХрм░рм┐рммрм╛ рмкрм╛рмЗрмБ рм╕рм╣рм╛рнЯрмдрм╛ рмХрнЗрмирнНрмжрнНрм░рм░рнЗ рмерм┐рммрм╛ рм╕рммрм┐рм╢рнЗрм╖ рмирм┐рм░рнНрмжрнНрмжрнЗрм╢рм╛рммрм│рнАрмХрнБ рмЕрмирнБрм╕рм░рмг рмХрм░рмирнНрмдрнБред
